About the bill
- Full Title
To amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
4 cosponsors (3D, 1R) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
- Related Bills
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.S. 3187 (Related)Food and Drug Administration Safety and Innovation Act
Enacted — Signed by the President
Jul 9, 2012H.R. 5651 (Related)Food and Drug Administration Reform Act of 2012
Last Action: May 30, 2012
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 3988 — 112th Congress: Generic Drug and Biosimilar User Fee Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr3988
“H.R. 3988 — 112th Congress: Generic Drug and Biosimilar User Fee Act of 2012.” www.GovTrack.us. 2012. May 2, 2016 <https://www.govtrack.us/congress/bills/112/hr3988>
|title=H.R. 3988 (112th)
|accessdate=May 2, 2016
|author=112th Congress (2012)
|date=February 8, 2012
|quote=Generic Drug and Biosimilar User Fee Act of 2012